TIOTROPIUM BROMIDE INHALATION SPRAY

TIOTROPIUM BROMIDE INHALATION SPRAY was reported 11487 times

TIOTROPIUM BROMIDE INHALATION SPRAY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMNIOTIC FLUID INDEX INCREASED 15 0.8333
1 GENITAL INFECTION VIRAL 11 0.4783
2 BRONCHOLITHIASIS 9 0.2903
3 HEART SOUNDS 20 0.2083
4 OCCUPATIONAL ASTHMA 8 0.1379
5 HYPERKALIURIA 6 0.1111
6 TOTAL LUNG CAPACITY INCREASED 24 0.0882
7 PROLONGED EXPIRATION 21 0.0802
8 CONGENITAL MEGAURETER 12 0.0622
9 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 32 0.0612
10 ATHEROEMBOLISM 8 0.0593
11 FOETAL MACROSOMIA 15 0.0540
12 LUNG DIFFUSION DISORDER 8 0.0510
13 LEFT-TO-RIGHT CARDIAC SHUNT 15 0.0508
14 KIDNEY DUPLEX 12 0.0500
15 RESPIRATORY GAS EXCHANGE DISORDER 18 0.0485
16 LYMPH NODE CALCIFICATION 9 0.0464
17 BREATH SOUNDS 6 0.0438
18 DOSE CALCULATION ERROR 25 0.0427
19 MUCOSAL HYPERTROPHY 6 0.0405
20 BRONCHOMALACIA 5 0.0379
21 REVERSIBLE AIRWAYS OBSTRUCTION 15 0.0295
22 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 444 0.0261
23 DEVICE PROGRAMMING ERROR 8 0.0252
24 VITAL CAPACITY DECREASED 11 0.0246
25 BRONCHIAL OBSTRUCTION 34 0.0242
26 HEART RATE 8 0.0230
27 ACQUIRED DIAPHRAGMATIC EVENTRATION 8 0.0225
28 BRONCHIAL WALL THICKENING 16 0.0223
29 MOTOR DEVELOPMENTAL DELAY 12 0.0208
30 OBSTRUCTIVE AIRWAYS DISORDER 227 0.0204
31 LUNG HYPERINFLATION 17 0.0198
32 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 7 0.0184
33 SPIROMETRY ABNORMAL 11 0.0184
34 DEPENDENCE ON OXYGEN THERAPY 9 0.0183
35 SPUTUM PURULENT 12 0.0182
36 PEAK EXPIRATORY FLOW RATE DECREASED 8 0.0182
37 CONGENITAL HYDRONEPHROSIS 12 0.0168
38 ASTHMATIC CRISIS 60 0.0164
39 VOCAL CORD DYSFUNCTION 8 0.0162
40 BLOOD IMMUNOGLOBULIN E INCREASED 39 0.0161
41 OESOPHAGEAL DILATATION 7 0.0158
42 ALLERGY TO PLANTS 7 0.0153
43 WHEEZING 846 0.0143
44 PRODUCT DELIVERY MECHANISM ISSUE 76 0.0141
45 FULL BLOOD COUNT ABNORMAL 145 0.0137
46 FEMALE STERILISATION 7 0.0136
47 ASTHMA 1510 0.0133
48 TOTAL LUNG CAPACITY DECREASED 21 0.0131
49 BLOOD COUNT ABNORMAL 195 0.0128
50 INFUSION SITE DISCHARGE 22 0.0125
51 BRONCHIAL HYPERREACTIVITY 15 0.0125
52 EOSINOPHIL COUNT INCREASED 103 0.0123
53 VULVAL DISORDER 8 0.0121
54 PNEUMONIA STREPTOCOCCAL 13 0.0119
55 SPUTUM DISCOLOURED 112 0.0118
56 BRONCHIAL SECRETION RETENTION 15 0.0118
57 BRONCHIECTASIS 78 0.0116
58 STRESS URINARY INCONTINENCE 12 0.0112
59 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 570 0.0109
60 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 520 0.0108
61 MULTIPLE ALLERGIES 79 0.0101
62 OXYGEN CONSUMPTION DECREASED 6 0.0099
63 POST-ACUTE COVID-19 SYNDROME 12 0.0097
64 OBSTRUCTIVE SLEEP APNOEA SYNDROME 14 0.0096
65 ADRENAL SUPPRESSION 8 0.0095
66 EOSINOPHIL COUNT ABNORMAL 7 0.0094
67 BREATH SOUNDS ABNORMAL 46 0.0093
68 CLOSTRIDIUM TEST POSITIVE 20 0.0091
69 PULMONARY FUNCTION TEST ABNORMAL 14 0.0090
70 EROSIVE DUODENITIS 7 0.0088
71 RHINITIS ALLERGIC 38 0.0085
72 GENITAL HERPES 13 0.0085
73 RESPIRATION ABNORMAL 58 0.0084
74 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 581 0.0082
75 DUST ALLERGY 8 0.0082
76 NASAL POLYPS 40 0.0081
77 INFUSION SITE BRUISING 17 0.0079
78 NOCTURNAL DYSPNOEA 10 0.0078
79 PULMONARY FUNCTION TEST DECREASED 34 0.0078
80 EMPHYSEMA 78 0.0077
81 RESPIRATORY TRACT IRRITATION 8 0.0077
82 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 7 0.0076
83 SPUTUM INCREASED 16 0.0074
84 PRODUCTIVE COUGH 346 0.0072
85 RHONCHI 10 0.0072
86 DRUG DELIVERY SYSTEM ISSUE 14 0.0071
87 OXYGEN SATURATION ABNORMAL 20 0.0070
88 UPPER-AIRWAY COUGH SYNDROME 58 0.0070
89 HYPOCHROMIC ANAEMIA 7 0.0069
90 RALES 40 0.0069
91 SPONTANEOUS HAEMORRHAGE 7 0.0068
92 CHOLANGIOCARCINOMA 10 0.0067
93 RESPIRATORY SYMPTOM 19 0.0067
94 VOCAL CORD DISORDER 13 0.0066
95 SEASONAL ALLERGY 92 0.0065
96 DEVICE INFUSION ISSUE 16 0.0064
97 LUNG OPACITY 17 0.0064
98 INFUSION SITE MASS 7 0.0064
99 PAINFUL RESPIRATION 15 0.0062
100 THROAT CLEARING 23 0.0061
101 DYSPNOEA EXERTIONAL 230 0.0061
102 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 10 0.0060
103 RESTRICTIVE PULMONARY DISEASE 7 0.0060
104 SENSE OF OPPRESSION 7 0.0059
105 PNEUMONIA PSEUDOMONAL 9 0.0059
106 INFUSION SITE RASH 8 0.0058
107 SECRETION DISCHARGE 73 0.0058
108 INFUSION SITE HAEMORRHAGE 19 0.0058
109 BRONCHITIS CHRONIC 14 0.0057
110 DEPRESSIVE SYMPTOM 20 0.0057
111 INFUSION SITE SWELLING 35 0.0056
112 SNORING 21 0.0055
113 PRURITUS GENITAL 13 0.0055
114 OXYGEN CONSUMPTION INCREASED 13 0.0054
115 OESOPHAGEAL SPASM 10 0.0054
116 LUNG CONSOLIDATION 15 0.0054
117 LIP INJURY 7 0.0053
118 CHRONIC SINUSITIS 20 0.0053
119 PNEUMONIA FUNGAL 21 0.0053
120 HALO VISION 6 0.0053
121 MYCOBACTERIAL INFECTION 9 0.0052
122 PULMONARY PAIN 15 0.0051
123 CARBON DIOXIDE INCREASED 7 0.0051
124 MITRAL VALVE DISEASE 9 0.0051
125 ESSENTIAL HYPERTENSION 9 0.0049
126 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 10 0.0049
127 INFUSION SITE WARMTH 6 0.0049
128 INFUSION SITE ERYTHEMA 41 0.0049
129 NASAL OBSTRUCTION 9 0.0048
130 RESPIRATORY TRACT CONGESTION 75 0.0047
131 INCREASED BRONCHIAL SECRETION 12 0.0047
132 MONOCYTE COUNT INCREASED 17 0.0047
133 PULMONARY MASS 69 0.0046
134 RHINITIS 37 0.0046
135 CARDIAC MURMUR 39 0.0045
136 INFUSION SITE PRURITUS 14 0.0044
137 SARCOIDOSIS 21 0.0044
138 CREPITATIONS 13 0.0044
139 MAST CELL ACTIVATION SYNDROME 6 0.0043
140 OXYGEN THERAPY 7 0.0043
141 OBSTRUCTION 17 0.0043
142 HYPERVOLAEMIA 21 0.0042
143 FORCED EXPIRATORY VOLUME DECREASED 12 0.0042
144 RESPIRATORY TRACT INFECTION 109 0.0042
145 SPEECH DISORDER DEVELOPMENTAL 12 0.0042
146 CHOKING 81 0.0041
147 CHRONIC RESPIRATORY FAILURE 5 0.0041
148 DYSPNOEA 2340 0.0041
149 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
150 HAEMATOLOGICAL INFECTION 10 0.0041
151 MIDDLE EAR EFFUSION 9 0.0041
152 BLOOD IMMUNOGLOBULIN G DECREASED 10 0.0040
153 GLOSSITIS 14 0.0039
154 LOWER RESPIRATORY TRACT INFECTION 178 0.0039
155 COUGH 1093 0.0039
156 RENAL MASS 8 0.0039
157 RESPIRATORY TRACT INFECTION VIRAL 9 0.0039
158 MEAN CELL HAEMOGLOBIN DECREASED 7 0.0038
159 APHONIA 53 0.0038
160 EXERCISE TOLERANCE DECREASED 21 0.0036
161 INFUSION SITE PAIN 47 0.0036
162 APPETITE DISORDER 24 0.0036
163 SLEEP APNOEA SYNDROME 69 0.0036
164 PNEUMONIA BACTERIAL 33 0.0036
165 CHEST X-RAY ABNORMAL 11 0.0036
166 OESOPHAGEAL PAIN 14 0.0035
167 POLYP 23 0.0035
168 CHEST DISCOMFORT 358 0.0035
169 POLYMYALGIA RHEUMATICA 11 0.0035
170 DRY THROAT 35 0.0034
171 EAR PRURITUS 12 0.0034
172 GINGIVAL DISORDER 13 0.0034
173 OPHTHALMIC HERPES ZOSTER 6 0.0033
174 NASAL OEDEMA 6 0.0033
175 CANDIDA INFECTION 56 0.0033
176 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
177 NASAL CONGESTION 186 0.0032
178 RIB FRACTURE 65 0.0032
179 BRONCHIOLITIS 11 0.0031
180 DYSPNOEA AT REST 9 0.0031
181 HYPERVENTILATION 18 0.0031
182 CHOKING SENSATION 17 0.0031
183 INSURANCE ISSUE 47 0.0031
184 LUNG NEOPLASM MALIGNANT 126 0.0031
185 STRIDOR 9 0.0031
186 BRONCHITIS 224 0.0030
187 OXYGEN SATURATION DECREASED 170 0.0030
188 LUNG DISORDER 144 0.0029
189 URINE FLOW DECREASED 7 0.0029
190 UPPER RESPIRATORY TRACT INFECTION 135 0.0029
191 PNEUMONIA 934 0.0029
192 BRONCHOSPASM 41 0.0029
193 ORAL DISCOMFORT 39 0.0028
194 EOSINOPHILIA 49 0.0028
195 HAEMOPTYSIS 77 0.0028
196 MIDDLE INSOMNIA 51 0.0027
197 INFUSION SITE EXTRAVASATION 17 0.0027
198 BODY TEMPERATURE ABNORMAL 5 0.0027
199 IRON DEFICIENCY 12 0.0027
200 SPINAL STENOSIS 11 0.0027
201 THROAT IRRITATION 119 0.0026
202 HAEMATOCRIT INCREASED 6 0.0026
203 ARTERIAL DISORDER 5 0.0026
204 DYSPHONIA 153 0.0026
205 MYCOBACTERIUM AVIUM COMPLEX INFECTION 7 0.0026
206 OESOPHAGEAL DISORDER 10 0.0026
207 EXTRA DOSE ADMINISTERED 105 0.0026
208 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
209 RESPIRATORY DISORDER 77 0.0026
210 PRODUCT QUALITY ISSUE 349 0.0026
211 RHINOVIRUS INFECTION 10 0.0026
212 ABDOMINAL WALL HAEMATOMA 5 0.0026
213 ACUTE RESPIRATORY FAILURE 49 0.0025
214 DRUG DELIVERY SYSTEM MALFUNCTION 13 0.0025
215 RED BLOOD CELL COUNT INCREASED 7 0.0025
216 EOSINOPHIL COUNT DECREASED 6 0.0025
217 URINARY HESITATION 6 0.0025
218 INTENTIONAL DEVICE MISUSE 11 0.0025
219 SKIN LACERATION 27 0.0025
220 WRONG DOSE 6 0.0025
221 SINUSITIS 254 0.0025
222 FRUSTRATION TOLERANCE DECREASED 20 0.0025
223 LYMPHOEDEMA 17 0.0025
224 CONJUNCTIVITIS 45 0.0024
225 SUFFOCATION FEELING 6 0.0024
226 DEVICE POWER SOURCE ISSUE 7 0.0024
227 OROPHARYNGEAL PAIN 220 0.0024
228 SINUS CONGESTION 32 0.0024
229 TONGUE DISCOMFORT 10 0.0024
230 FLANK PAIN 22 0.0023
231 INFUSION SITE REACTION 7 0.0023
232 DECREASED ACTIVITY 25 0.0023
233 ATELECTASIS 22 0.0023
234 IDIOPATHIC PULMONARY FIBROSIS 9 0.0023
235 PULMONARY CONGESTION 30 0.0023
236 MACULAR DEGENERATION 27 0.0023
237 OESOPHAGEAL CANDIDIASIS 9 0.0023
238 INFLUENZA 251 0.0022
239 VIRAL INFECTION 74 0.0022
240 SINUS DISORDER 44 0.0022
241 PSEUDOMONAS INFECTION 19 0.0022
242 BLOOD LOSS ANAEMIA 5 0.0022
243 PNEUMONIA VIRAL 7 0.0022
244 HAEMOGLOBIN INCREASED 10 0.0022
245 EAR DISORDER 10 0.0022
246 PNEUMONITIS 59 0.0022
247 PHARYNGEAL SWELLING 21 0.0021
248 RHINORRHOEA 138 0.0021
249 THROAT CANCER 9 0.0021
250 ORAL CANDIDIASIS 28 0.0021
251 SUSPECTED COVID-19 7 0.0021
252 NEAR DEATH EXPERIENCE 7 0.0021
253 GASTROINTESTINAL INFECTION 19 0.0021
254 WRIST FRACTURE 25 0.0021
255 THYROID MASS 8 0.0021
256 PNEUMOTHORAX 33 0.0021
257 BILIARY COLIC 6 0.0021
258 ADRENAL INSUFFICIENCY 25 0.0021
259 ILLNESS 212 0.0021
260 ABNORMAL LOSS OF WEIGHT 14 0.0021
261 LEFT VENTRICULAR FAILURE 7 0.0020
262 COVID-19 PNEUMONIA 24 0.0020
263 HYPOPNOEA 7 0.0020
264 BLOOD TEST ABNORMAL 28 0.0020
265 INTRACRANIAL ANEURYSM 8 0.0020
266 KIDNEY INFECTION 39 0.0020
267 CYSTIC FIBROSIS 11 0.0020
268 GLAUCOMA 38 0.0020
269 RETCHING 42 0.0020
270 MUSCLE STRAIN 17 0.0020
271 COVID-19 344 0.0020
272 GASTROOESOPHAGEAL REFLUX DISEASE 157 0.0019
273 INCREASED UPPER AIRWAY SECRETION 10 0.0019
274 FOOD ALLERGY 15 0.0019
275 PRODUCT DISTRIBUTION ISSUE 18 0.0019
276 CONCUSSION 15 0.0019
277 SOCIAL PROBLEM 8 0.0019
278 PELVIC FRACTURE 15 0.0019
279 CAROTID ARTERY OCCLUSION 7 0.0019
280 NASAL DRYNESS 12 0.0019
281 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
282 SKIN EROSION 6 0.0019
283 EYE DISORDER 61 0.0019
284 PLEURISY 11 0.0019
285 HEPATIC LESION 8 0.0018
286 HORDEOLUM 8 0.0018
287 POOR VENOUS ACCESS 19 0.0018
288 PULMONARY THROMBOSIS 20 0.0018
289 SNEEZING 41 0.0018
290 HYPOXIA 64 0.0018
291 UPPER LIMB FRACTURE 36 0.0018
292 HEART RATE ABNORMAL 10 0.0018
293 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
294 OROPHARYNGEAL DISCOMFORT 16 0.0018
295 RENAL CYST 14 0.0018
296 TOOTH INFECTION 23 0.0017
297 SKIN ATROPHY 10 0.0017
298 AORTIC ANEURYSM 13 0.0017
299 SKIN ABRASION 8 0.0017
300 COMPRESSION FRACTURE 9 0.0017
301 PRODUCT PRESCRIBING ERROR 40 0.0017
302 CYSTITIS 53 0.0017
303 EAR DISCOMFORT 17 0.0017
304 CRANIOCEREBRAL INJURY 5 0.0017
305 SCLERODERMA 6 0.0016
306 LUNG NEOPLASM 7 0.0016
307 PULMONARY HYPERTENSION 34 0.0016
308 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
309 BLOOD BLISTER 5 0.0016
310 BRAIN FOG 25 0.0016
311 SARS-COV-2 TEST POSITIVE 21 0.0016
312 DRY MOUTH 129 0.0016
313 DERMATITIS CONTACT 18 0.0016
314 EAR INFECTION 42 0.0016
315 PARANASAL SINUS HYPERSECRETION 6 0.0016
316 BILE DUCT STONE 5 0.0016
317 OBESITY 25 0.0016
318 CATARACT 93 0.0016
319 HAEMOGLOBIN ABNORMAL 10 0.0016
320 ABDOMINAL HERNIA 7 0.0015
321 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
322 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
323 SINUS HEADACHE 9 0.0015
324 ANXIETY DISORDER 5 0.0015
325 FLUID RETENTION 76 0.0015
326 FOOD POISONING 8 0.0015
327 FOETAL GROWTH RESTRICTION 9 0.0015
328 WRONG PRODUCT ADMINISTERED 10 0.0015
329 NASOPHARYNGITIS 271 0.0015
330 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 8 0.0015
331 TRIGGER FINGER 6 0.0015
332 DEVICE MALFUNCTION 103 0.0015
333 HYPOVOLAEMIC SHOCK 7 0.0015
334 RESPIRATORY DISTRESS 40 0.0014
335 SPINAL FRACTURE 29 0.0014
336 ANAL INCONTINENCE 13 0.0014
337 GASTROENTERITIS VIRAL 26 0.0014
338 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
339 HYPERPYREXIA 6 0.0014
340 QUALITY OF LIFE DECREASED 19 0.0014
341 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
342 HAND FRACTURE 10 0.0014
343 BLADDER DISORDER 14 0.0014
344 BLOOD PRESSURE ABNORMAL 28 0.0014
345 JOINT INJURY 30 0.0014
346 LIMB INJURY 38 0.0014
347 ANGINA PECTORIS 40 0.0014
348 NASAL DISCOMFORT 11 0.0014
349 IMMOBILE 6 0.0014
350 SOMNAMBULISM 9 0.0014
351 PHYSICAL DISABILITY 6 0.0014
352 PULMONARY FIBROSIS 26 0.0014
353 DEVICE DELIVERY SYSTEM ISSUE 37 0.0014
354 HYPERCHOLESTEROLAEMIA 13 0.0013
355 HERNIA 26 0.0013
356 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 240 0.0013
357 ATRIAL FIBRILLATION 129 0.0013
358 EXPOSURE VIA SKIN CONTACT 34 0.0013
359 EYE OPERATION 6 0.0013
360 INTENTIONAL DOSE OMISSION 37 0.0013
361 ARTHRITIS INFECTIVE 6 0.0013
362 MUSCULOSKELETAL CHEST PAIN 20 0.0013
363 INFECTION 187 0.0013
364 PHARYNGITIS 16 0.0013
365 RIGHT VENTRICULAR FAILURE 9 0.0013
366 ORAL HERPES 25 0.0013
367 FOOT FRACTURE 24 0.0013
368 PRODUCT DOSE OMISSION ISSUE 372 0.0013
369 OSTEOPOROSIS 52 0.0013
370 INTENTIONAL PRODUCT USE ISSUE 110 0.0013
371 DYSURIA 46 0.0012
372 HUMERUS FRACTURE 6 0.0012
373 PRODUCT DISPENSING ERROR 27 0.0012
374 HYPOACUSIS 53 0.0012
375 VITAMIN D DEFICIENCY 12 0.0012
376 POST PROCEDURAL INFECTION 10 0.0012
377 ASPHYXIA 10 0.0012
378 LUNG INFECTION 19 0.0012
379 LIGAMENT SPRAIN 12 0.0012
380 CORONAVIRUS INFECTION 8 0.0012
381 SPINAL COMPRESSION FRACTURE 10 0.0012
382 FALL 401 0.0012
383 DEVICE USE ISSUE 21 0.0012
384 BACK INJURY 13 0.0012
385 DEVICE PHYSICAL PROPERTY ISSUE 9 0.0012
386 CARDIAC FAILURE CHRONIC 5 0.0012
387 GOUT 21 0.0012
388 BACK DISORDER 19 0.0012
389 ATRIOVENTRICULAR BLOCK 9 0.0012
390 RESPIRATORY FAILURE 84 0.0012
391 FIBROMYALGIA 28 0.0012
392 EYE INFECTION 13 0.0012
393 BONE CANCER 5 0.0011
394 PRODUCT ADMINISTRATION ERROR 23 0.0011
395 NEPHROLITHIASIS 52 0.0011
396 CATHETERISATION CARDIAC 5 0.0011
397 HEART RATE INCREASED 111 0.0011
398 URINARY TRACT INFECTION 191 0.0011
399 HIP FRACTURE 36 0.0011
400 ORAL PAIN 25 0.0011
401 PANIC REACTION 8 0.0011
402 INABILITY TO AFFORD MEDICATION 11 0.0011
403 HEAD INJURY 35 0.0011
404 FOREIGN BODY SENSATION IN EYES 7 0.0011
405 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
406 ASPIRATION 12 0.0011
407 BLOOD IRON DECREASED 13 0.0011
408 LOWER LIMB FRACTURE 21 0.0011
409 ORAL DISORDER 8 0.0011
410 PROSTATIC DISORDER 6 0.0011
411 CHEST PAIN 201 0.0011
412 HIATUS HERNIA 14 0.0011
413 PRODUCT USE COMPLAINT 17 0.0011
414 BACTERIAL INFECTION 20 0.0011
415 CARDIAC DISORDER 100 0.0011
416 ASPERGILLUS INFECTION 7 0.0011
417 DEVICE ISSUE 95 0.0011
418 FACIAL PARALYSIS 9 0.0011
419 TROPONIN INCREASED 8 0.0011
420 HYPONATRAEMIA 59 0.0010
421 MUSCULOSKELETAL DISCOMFORT 18 0.0010
422 IMPAIRED QUALITY OF LIFE 15 0.0010
423 BREAST MASS 7 0.0010
424 EYE PRURITUS 35 0.0010
425 POST PROCEDURAL COMPLICATION 20 0.0010
426 MOUTH SWELLING 6 0.0010
427 THYROID DISORDER 16 0.0010
428 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
429 ELECTROLYTE IMBALANCE 12 0.0010
430 POST PROCEDURAL HAEMORRHAGE 12 0.0010
431 EAR PAIN 20 0.0010
432 IMPAIRED GASTRIC EMPTYING 14 0.0010
433 PRODUCT COMPLAINT 26 0.0010
434 DIABETES MELLITUS 78 0.0010
435 IMMUNOSUPPRESSION 9 0.0010
436 HEART RATE IRREGULAR 23 0.0010
437 AFFECTIVE DISORDER 8 0.0010
438 ARTHRITIS 80 0.0010
439 PHARYNGITIS STREPTOCOCCAL 11 0.0010
440 FURUNCLE 8 0.0010
441 CARDIAC FAILURE CONGESTIVE 81 0.0010
442 FACIAL PAIN 9 0.0010
443 SLEEP DISORDER 71 0.0010
444 NEOPLASM MALIGNANT 67 0.0010
445 SYMPTOM RECURRENCE 6 0.0010
446 ATRIAL FLUTTER 8 0.0010
447 PLATELET COUNT INCREASED 13 0.0010
448 TOOTHACHE 18 0.0010
449 PRODUCT PHYSICAL ISSUE 20 0.0010
450 PULMONARY OEDEMA 44 0.0010
451 NEUTROPHIL COUNT INCREASED 10 0.0010
452 MIGRAINE 93 0.0010
453 CACHEXIA 5 0.0010
454 CARDIAC FAILURE 78 0.0010
455 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
456 THROAT TIGHTNESS 26 0.0010
457 DISABILITY 19 0.0010
458 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
459 PRODUCT TASTE ABNORMAL 13 0.0010
460 FUNGAL INFECTION 32 0.0010
461 INTENTIONAL UNDERDOSE 7 0.0010
462 NEOPLASM 11 0.0010
463 PHOTOPSIA 6 0.0009
464 ARTHROPOD BITE 7 0.0009
465 MALAISE 412 0.0009
466 HOSPITALISATION 144 0.0009
467 BODY HEIGHT DECREASED 10 0.0009
468 ROTATOR CUFF SYNDROME 12 0.0009
469 POOR QUALITY SLEEP 20 0.0009
470 INTESTINAL OBSTRUCTION 35 0.0009
471 DEVICE DEFECTIVE 16 0.0009
472 DEVICE FAILURE 14 0.0009
473 WOUND INFECTION 10 0.0009
474 HOSPICE CARE 9 0.0009
475 SPINAL OSTEOARTHRITIS 8 0.0009
476 LYMPHADENOPATHY 32 0.0009
477 RED BLOOD CELL SEDIMENTATION RATE INCREASED 10 0.0009
478 PERIPHERAL SWELLING 139 0.0009
479 HYPERTENSIVE CRISIS 10 0.0009
480 POST-TRAUMATIC STRESS DISORDER 6 0.0009
481 DEMENTIA 25 0.0009
482 CARDIOMEGALY 11 0.0009
483 SMALL INTESTINAL OBSTRUCTION 11 0.0009
484 PLEURAL EFFUSION 54 0.0009
485 PRODUCT LABEL ISSUE 6 0.0009
486 TOOTH ABSCESS 9 0.0009
487 BLOOD PRESSURE INCREASED 135 0.0009
488 DRUG EFFECT INCOMPLETE 32 0.0009
489 DEAFNESS 23 0.0009
490 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
491 INFARCTION 6 0.0009
492 GASTRITIS 23 0.0009
493 UROSEPSIS 8 0.0009
494 EYE DISCHARGE 9 0.0009
495 WEIGHT FLUCTUATION 9 0.0009
496 EXTRASYSTOLES 6 0.0009
497 VISION BLURRED 118 0.0009
498 HYPERKALAEMIA 30 0.0009
499 JOINT DISLOCATION 9 0.0009
500 BLINDNESS UNILATERAL 12 0.0008
501 ANAPHYLACTIC REACTION 47 0.0008
502 RENAL PAIN 9 0.0008
503 LEUKAEMIA 8 0.0008
504 DIVERTICULUM 6 0.0008
505 BACTERAEMIA 10 0.0008
506 PRODUCT PACKAGING ISSUE 8 0.0008
507 ANKLE FRACTURE 13 0.0008
508 GAIT INABILITY 28 0.0008
509 BEDRIDDEN 11 0.0008
510 HERPES ZOSTER 48 0.0008
511 WEIGHT DECREASED 232 0.0008
512 TONGUE DISORDER 6 0.0008
513 EPISTAXIS 62 0.0008
514 LOCALISED INFECTION 20 0.0008
515 NOCTURIA 10 0.0008
516 OFF LABEL USE 716 0.0008
517 PRODUCT CONTAINER ISSUE 7 0.0008
518 TOOTH FRACTURE 9 0.0008
519 CARDIAC OPERATION 7 0.0008
520 HEPATOMEGALY 8 0.0008
521 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
522 DEPRESSED MOOD 43 0.0008
523 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
524 SPINAL OPERATION 10 0.0008
525 THROMBOSIS 65 0.0008
526 SKIN SWELLING 7 0.0008
527 ASTHENIA 302 0.0008
528 ARRHYTHMIA 38 0.0008
529 HYPERSOMNIA 23 0.0008
530 INTESTINAL PERFORATION 9 0.0008
531 OCULAR DISCOMFORT 9 0.0008
532 BLOOD CALCIUM INCREASED 7 0.0008
533 RESPIRATORY ARREST 22 0.0008
534 HEART RATE DECREASED 28 0.0008
535 CHROMATURIA 18 0.0008
536 HYPOAESTHESIA ORAL 12 0.0008
537 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
538 SKIN CANCER 17 0.0008
539 SYNCOPE 79 0.0008
540 SCAB 9 0.0008
541 TASTE DISORDER 16 0.0008
542 INTERNAL HAEMORRHAGE 9 0.0008
543 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
544 EYE SWELLING 29 0.0008
545 URINARY RETENTION 26 0.0008
546 LYMPHOMA 12 0.0008
547 URINARY INCONTINENCE 23 0.0008
548 CARDIAC FLUTTER 5 0.0008
549 RENAL DISORDER 36 0.0008
550 PRODUCT USE ISSUE 145 0.0008
551 SEPSIS 86 0.0008
552 BACK PAIN 179 0.0008
553 HYPERTENSION 163 0.0008
554 TENDERNESS 8 0.0008
555 HEMIPARESIS 13 0.0008
556 POLLAKIURIA 32 0.0008
557 EXOSTOSIS 7 0.0008
558 SPEECH DISORDER 40 0.0008
559 BRAIN NEOPLASM 7 0.0008
560 LACRIMATION INCREASED 23 0.0008
561 INJECTION SITE DISCOMFORT 8 0.0008
562 PNEUMONIA ASPIRATION 19 0.0008
563 NERVE COMPRESSION 7 0.0008
564 DIZZINESS 378 0.0008
565 ACCIDENT 9 0.0008
566 HEPATIC STEATOSIS 14 0.0008
567 HEADACHE 469 0.0007
568 PHOTOPHOBIA 14 0.0007
569 PALPITATIONS 87 0.0007
570 PAIN IN JAW 21 0.0007
571 COLON CANCER 11 0.0007
572 SHOCK HAEMORRHAGIC 6 0.0007
573 BIPOLAR DISORDER 8 0.0007
574 PERICARDIAL EFFUSION 17 0.0007
575 FEELING JITTERY 14 0.0007
576 CEREBROVASCULAR ACCIDENT 124 0.0007
577 OEDEMA PERIPHERAL 89 0.0007
578 ESCHERICHIA INFECTION 6 0.0007
579 GALLBLADDER DISORDER 13 0.0007
580 EYE PAIN 41 0.0007
581 DRY EYE 36 0.0007
582 LIP SWELLING 24 0.0007
583 TOOTH DISORDER 16 0.0007
584 INFLAMMATION 37 0.0007
585 KNEE ARTHROPLASTY 15 0.0007
586 SENSATION OF FOREIGN BODY 6 0.0007
587 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
588 DISCOMFORT 43 0.0007
589 INTRAOCULAR PRESSURE INCREASED 9 0.0007
590 VITAMIN D DECREASED 6 0.0007
591 MICTURITION URGENCY 8 0.0007
592 PYREXIA 242 0.0007
593 CONTUSION 67 0.0007
594 PULMONARY EMBOLISM 66 0.0007
595 VISUAL IMPAIRMENT 86 0.0007
596 HYPOKALAEMIA 32 0.0007
597 SCIATICA 11 0.0007
598 BLOOD SODIUM DECREASED 13 0.0007
599 ORTHOSTATIC HYPOTENSION 12 0.0007
600 FEELING ABNORMAL 165 0.0007
601 PRODUCT USE IN UNAPPROVED INDICATION 170 0.0007
602 DIVERTICULITIS 19 0.0007
603 INJECTION SITE RASH 21 0.0007
604 ARTHROPATHY 38 0.0007
605 RESPIRATORY RATE INCREASED 6 0.0007
606 INTENTIONAL PRODUCT MISUSE 59 0.0007
607 THERAPY INTERRUPTED 48 0.0007
608 LOSS OF CONSCIOUSNESS 86 0.0007
609 CEREBRAL HAEMORRHAGE 24 0.0007
610 RASH ERYTHEMATOUS 32 0.0007
611 THERAPEUTIC RESPONSE UNEXPECTED 30 0.0007
612 THERAPY NON-RESPONDER 30 0.0007
613 INCONTINENCE 7 0.0007
614 CONDITION AGGRAVATED 200 0.0007
615 DEVICE MECHANICAL ISSUE 9 0.0007
616 CELLULITIS 33 0.0007
617 RETINAL DETACHMENT 6 0.0007
618 FATIGUE 508 0.0007
619 INCREASED TENDENCY TO BRUISE 6 0.0007
620 NIGHT SWEATS 21 0.0007
621 NERVOUSNESS 34 0.0007
622 TREMOR 108 0.0007
623 DYSPEPSIA 64 0.0006
624 PHARYNGEAL OEDEMA 10 0.0006
625 PROCEDURAL PAIN 18 0.0006
626 FEELING COLD 18 0.0006
627 LIMB DISCOMFORT 20 0.0006
628 TENDONITIS 10 0.0006
629 CARPAL TUNNEL SYNDROME 9 0.0006
630 SWELLING 60 0.0006
631 OESOPHAGITIS 7 0.0006
632 SWOLLEN TONGUE 20 0.0006
633 CHILLS 75 0.0006
634 ARTERIOSCLEROSIS 6 0.0006
635 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
636 NERVE INJURY 7 0.0006
637 LETHARGY 36 0.0006
638 SKIN INFECTION 7 0.0006
639 PARAESTHESIA ORAL 9 0.0006
640 ANXIETY 177 0.0006
641 PRESCRIBED OVERDOSE 12 0.0006
642 HYPOKINESIA 9 0.0006
643 HYPERSENSITIVITY 115 0.0006
644 TACHYCARDIA 55 0.0006
645 DIZZINESS POSTURAL 6 0.0006
646 BLOOD PRESSURE DECREASED 41 0.0006
647 DIPLOPIA 16 0.0006
648 AUTOIMMUNE DISORDER 6 0.0006
649 SKIN FISSURES 12 0.0006
650 ECZEMA 32 0.0006
651 DRUG INTOLERANCE 59 0.0006
652 VITREOUS FLOATERS 6 0.0006
653 IMMUNODEFICIENCY 9 0.0006
654 ACUTE CORONARY SYNDROME 5 0.0006
655 BONE DISORDER 11 0.0006
656 HYPOTENSION 121 0.0006
657 WEIGHT INCREASED 134 0.0006
658 ATRIAL SEPTAL DEFECT 5 0.0006
659 OSTEOPENIA 9 0.0006
660 FACE OEDEMA 10 0.0006
661 NECK PAIN 33 0.0006
662 MYOCARDIAL INFARCTION 103 0.0006
663 OCULAR HYPERAEMIA 28 0.0006
664 MOTOR DYSFUNCTION 6 0.0006
665 BODY TEMPERATURE INCREASED 12 0.0006
666 ANGIOEDEMA 26 0.0006
667 TINNITUS 27 0.0006
668 HIP ARTHROPLASTY 9 0.0006
669 GAIT DISTURBANCE 112 0.0006
670 DRUG INEFFECTIVE 771 0.0006
671 INITIAL INSOMNIA 6 0.0006
672 DEVICE RELATED INFECTION 9 0.0006
673 PRODUCT PREPARATION ERROR 12 0.0006
674 CORONARY ARTERY OCCLUSION 8 0.0006
675 BLOOD PRESSURE FLUCTUATION 14 0.0006
676 MEMORY IMPAIRMENT 80 0.0006
677 ACUTE MYOCARDIAL INFARCTION 17 0.0006
678 INSOMNIA 153 0.0006
679 ROAD TRAFFIC ACCIDENT 24 0.0006
680 URTICARIA 96 0.0006
681 OEDEMA 31 0.0006
682 FEELING HOT 35 0.0006
683 DEHYDRATION 76 0.0006
684 SKIN DISORDER 19 0.0006
685 SCRATCH 6 0.0006
686 DEVICE OCCLUSION 8 0.0006
687 COLD SWEAT 10 0.0006
688 TENDON RUPTURE 7 0.0006
689 OSTEOARTHRITIS 24 0.0006
690 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
691 BLOOD POTASSIUM DECREASED 17 0.0006
692 HEAD DISCOMFORT 10 0.0006
693 CYST 7 0.0006
694 DIALYSIS 8 0.0006
695 HYPOTHYROIDISM 18 0.0006
696 METABOLIC ACIDOSIS 18 0.0006
697 SURGERY 33 0.0006
698 INFUSION RELATED REACTION 37 0.0006
699 VERTIGO 34 0.0006
700 BLOOD CHOLESTEROL INCREASED 26 0.0006
701 CARDIOGENIC SHOCK 8 0.0006
702 INJURY 39 0.0006
703 ABDOMINAL PAIN UPPER 114 0.0006
704 PRESCRIBED UNDERDOSE 11 0.0006
705 PRODUCT PRESCRIBING ISSUE 12 0.0006
706 FEMUR FRACTURE 17 0.0005
707 PANIC ATTACK 20 0.0005
708 SKIN LESION 15 0.0005
709 DENTAL CARIES 6 0.0005
710 MEDICATION ERROR 30 0.0005
711 AMNESIA 35 0.0005
712 BLOOD UREA INCREASED 9 0.0005
713 MALNUTRITION 6 0.0005
714 PAIN IN EXTREMITY 157 0.0005
715 ABDOMINAL PAIN 123 0.0005
716 BLOOD URINE PRESENT 10 0.0005
717 ILL-DEFINED DISORDER 32 0.0005
718 GASTRIC ULCER 10 0.0005
719 ACCIDENTAL EXPOSURE TO PRODUCT 54 0.0005
720 RENAL IMPAIRMENT 44 0.0005
721 ARTHRALGIA 216 0.0005
722 MUSCULAR WEAKNESS 59 0.0005
723 GENERAL PHYSICAL HEALTH DETERIORATION 60 0.0005
724 DEVICE USE ERROR 18 0.0005
725 PRURITUS 199 0.0005
726 STAPHYLOCOCCAL INFECTION 17 0.0005
727 NEEDLE ISSUE 15 0.0005
728 VASCULITIS 6 0.0005
729 RASH MACULAR 18 0.0005
730 PALLOR 14 0.0005
731 PAIN 316 0.0005
732 ABDOMINAL PAIN LOWER 13 0.0005
733 BURNING SENSATION 36 0.0005
734 TYPE 2 DIABETES MELLITUS 17 0.0005
735 DISEASE RECURRENCE 24 0.0005
736 HAEMATOCRIT DECREASED 10 0.0005
737 RHABDOMYOLYSIS 21 0.0005
738 GASTROINTESTINAL HAEMORRHAGE 42 0.0005
739 COLITIS 19 0.0005
740 DYSGEUSIA 37 0.0005
741 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
742 CONSTIPATION 108 0.0005
743 RESTLESS LEGS SYNDROME 9 0.0005
744 FLATULENCE 28 0.0005
745 PRESYNCOPE 12 0.0005
746 DEATH 425 0.0005
747 GASTROINTESTINAL DISORDER 44 0.0005
748 INJECTION SITE URTICARIA 12 0.0005
749 SUBDURAL HAEMATOMA 7 0.0005
750 IMPAIRED HEALING 16 0.0005
751 CHRONIC KIDNEY DISEASE 37 0.0005
752 SOMNOLENCE 98 0.0005
753 EYE IRRITATION 28 0.0005
754 ANOSMIA 7 0.0005
755 HYPERTHYROIDISM 7 0.0005
756 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
757 PRODUCT AVAILABILITY ISSUE 11 0.0005
758 THINKING ABNORMAL 9 0.0005
759 ILEUS 6 0.0005
760 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
761 AGEUSIA 12 0.0005
762 RASH PRURITIC 26 0.0005
763 STOMATITIS 29 0.0005
764 MYALGIA 81 0.0005
765 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
766 FRACTURE 9 0.0005
767 DERMATITIS ATOPIC 25 0.0005
768 LIVER DISORDER 21 0.0005
769 HYPERHIDROSIS 61 0.0005
770 MOBILITY DECREASED 34 0.0005
771 RASH 206 0.0005
772 EATING DISORDER 10 0.0005
773 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 95 0.0005
774 MUSCLE SPASMS 86 0.0005
775 IRRITABLE BOWEL SYNDROME 10 0.0005
776 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
777 ABDOMINAL DISCOMFORT 78 0.0005
778 SKIN ULCER 12 0.0005
779 AGITATION 34 0.0005
780 PRURITUS GENERALISED 10 0.0005
781 HAEMORRHOIDS 9 0.0005
782 HYPOAESTHESIA 69 0.0005
783 NODULE 6 0.0005
784 MENTAL DISORDER 20 0.0005
785 VOMITING 216 0.0005
786 DECREASED APPETITE 106 0.0005
787 JOINT SWELLING 55 0.0005
788 IMMUNE SYSTEM DISORDER 6 0.0005
789 NEURALGIA 11 0.0005
790 DYSARTHRIA 17 0.0005
791 INJECTION SITE ERYTHEMA 56 0.0005
792 INJECTION SITE BRUISING 36 0.0005
793 BALANCE DISORDER 39 0.0005
794 ABDOMINAL DISTENSION 47 0.0004
795 EYE HAEMORRHAGE 6 0.0004
796 INFLUENZA LIKE ILLNESS 37 0.0004
797 THERAPY PARTIAL RESPONDER 7 0.0004
798 INJECTION SITE PRURITUS 30 0.0004
799 THIRST 8 0.0004
800 ANAEMIA 85 0.0004
801 INJECTION SITE SWELLING 34 0.0004
802 OSTEOMYELITIS 8 0.0004
803 HALLUCINATION, AUDITORY 7 0.0004
804 HAEMORRHAGE 46 0.0004
805 PREMATURE DELIVERY 7 0.0004
806 TREATMENT NONCOMPLIANCE 24 0.0004
807 ACUTE KIDNEY INJURY 67 0.0004
808 INTENTIONAL OVERDOSE 28 0.0004
809 DIARRHOEA 281 0.0004
810 HAEMATEMESIS 11 0.0004
811 BRADYCARDIA 23 0.0004
812 INJECTION SITE MASS 16 0.0004
813 MUSCLE TIGHTNESS 7 0.0004
814 DYSPHAGIA 41 0.0004
815 DEPRESSION 98 0.0004
816 SWELLING FACE 28 0.0004
817 NAUSEA 340 0.0004
818 DERMATITIS 9 0.0004
819 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
820 INJECTION SITE PAIN 131 0.0004
821 HAEMATOMA 11 0.0004
822 RENAL FAILURE 56 0.0004
823 CONFUSIONAL STATE 68 0.0004
824 ERUCTATION 8 0.0004
825 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
826 CARDIAC ARREST 34 0.0004
827 GASTROENTERITIS 6 0.0004
828 SCAR 7 0.0004
829 HAEMATURIA 14 0.0004
830 COGNITIVE DISORDER 19 0.0004
831 MOVEMENT DISORDER 13 0.0004
832 SKIN HAEMORRHAGE 6 0.0004
833 GLOSSODYNIA 9 0.0004
834 MUSCULOSKELETAL PAIN 21 0.0004
835 HAEMATOCHEZIA 22 0.0004
836 PRODUCT DOSE OMISSION 26 0.0004
837 BLOOD CREATININE INCREASED 26 0.0004
838 THERAPEUTIC RESPONSE DECREASED 24 0.0004
839 FEEDING DISORDER 8 0.0004
840 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
841 BONE PAIN 23 0.0004
842 DRUG DISPENSING ERROR 6 0.0004
843 INTERSTITIAL LUNG DISEASE 19 0.0004
844 SKIN DISCOLOURATION 18 0.0004
845 HALLUCINATION 29 0.0004
846 BASAL CELL CARCINOMA 6 0.0004
847 ACCIDENTAL OVERDOSE 14 0.0004
848 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
849 ULCER 6 0.0004
850 DELIRIUM 13 0.0004
851 SKIN IRRITATION 17 0.0004
852 UNEVALUABLE EVENT 28 0.0004
853 ERYTHEMA 76 0.0004
854 BLOOD POTASSIUM INCREASED 6 0.0004
855 SEPTIC SHOCK 16 0.0004
856 INCREASED APPETITE 7 0.0004
857 CHOLELITHIASIS 12 0.0004
858 APHASIA 11 0.0004
859 HAEMOGLOBIN DECREASED 37 0.0004
860 MENTAL STATUS CHANGES 10 0.0004
861 WOUND 10 0.0004
862 FOETAL EXPOSURE DURING PREGNANCY 29 0.0004
863 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
864 CIRCULATORY COLLAPSE 6 0.0004
865 HYPOPHAGIA 9 0.0004
866 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
867 ANAPHYLACTIC SHOCK 9 0.0003
868 HOT FLUSH 26 0.0003
869 BLINDNESS 14 0.0003
870 RHEUMATOID ARTHRITIS 39 0.0003
871 ANHEDONIA 9 0.0003
872 DYSSTASIA 10 0.0003
873 INCORRECT DOSE ADMINISTERED 78 0.0003
874 CARDIOMYOPATHY 5 0.0003
875 NEUROPATHY PERIPHERAL 32 0.0003
876 HEPATIC CANCER 8 0.0003
877 PREMATURE BABY 10 0.0003
878 MOUTH ULCERATION 7 0.0003
879 THERAPY CESSATION 17 0.0003
880 MENTAL IMPAIRMENT 8 0.0003
881 DISORIENTATION 13 0.0003
882 RECTAL HAEMORRHAGE 14 0.0003
883 BLISTER 18 0.0003
884 HEPATIC CIRRHOSIS 6 0.0003
885 CYANOSIS 5 0.0003
886 NIGHTMARE 11 0.0003
887 OVERDOSE 68 0.0003
888 COMA 15 0.0003
889 RASH PAPULAR 7 0.0003
890 DRUG PRESCRIBING ERROR 6 0.0003
891 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
892 EXPOSURE DURING PREGNANCY 19 0.0003
893 INJECTION SITE REACTION 21 0.0003
894 FLUSHING 31 0.0003
895 PSYCHOTIC DISORDER 9 0.0003
896 PANCYTOPENIA 17 0.0003
897 EXPIRED PRODUCT ADMINISTERED 10 0.0003
898 PARAESTHESIA 47 0.0003
899 FEAR 8 0.0003
900 CORONARY ARTERY DISEASE 9 0.0003
901 DISTURBANCE IN ATTENTION 16 0.0003
902 MOOD ALTERED 8 0.0003
903 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
904 CARDIO-RESPIRATORY ARREST 12 0.0003
905 SKIN EXFOLIATION 24 0.0003
906 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
907 SEIZURE 32 0.0003
908 PANCREATIC CARCINOMA 8 0.0003
909 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
910 GASTRIC CANCER 7 0.0003
911 HYPERGLYCAEMIA 10 0.0003
912 MUSCULOSKELETAL STIFFNESS 24 0.0003
913 UNRESPONSIVE TO STIMULI 7 0.0003
914 LABORATORY TEST ABNORMAL 8 0.0003
915 BLOOD GLUCOSE ABNORMAL 5 0.0003
916 DRY SKIN 36 0.0003
917 ADVERSE DRUG REACTION 24 0.0003
918 JOINT STIFFNESS 7 0.0003
919 GASTRIC DISORDER 9 0.0003
920 BREAST CANCER FEMALE 7 0.0003
921 DEEP VEIN THROMBOSIS 17 0.0003
922 SHOCK 6 0.0003
923 MUSCLE TWITCHING 6 0.0003
924 PAIN OF SKIN 7 0.0003
925 BREAST CANCER 24 0.0003
926 DEVICE DIFFICULT TO USE 17 0.0003
927 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
928 BLOOD GLUCOSE DECREASED 12 0.0002
929 HEPATIC ENZYME INCREASED 17 0.0002
930 DRUG INTERACTION 39 0.0002
931 LIVER INJURY 6 0.0002
932 ASCITES 7 0.0002
933 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
934 ALOPECIA 46 0.0002
935 RASH GENERALISED 6 0.0002
936 EMOTIONAL DISORDER 7 0.0002
937 PANCREATITIS 12 0.0002
938 PROSTATE CANCER 18 0.0002
939 FREQUENT BOWEL MOVEMENTS 6 0.0002
940 AGGRESSION 11 0.0002
941 UNDERDOSE 16 0.0002
942 SUICIDAL IDEATION 20 0.0002
943 VISUAL ACUITY REDUCED 7 0.0002
944 PRODUCT SUBSTITUTION ISSUE 12 0.0002
945 ANGER 7 0.0002
946 HYPOGLYCAEMIA 10 0.0002
947 RENAL INJURY 6 0.0002
948 PSORIASIS 26 0.0002
949 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
950 DEVICE BREAKAGE 8 0.0002
951 BLOOD GLUCOSE INCREASED 37 0.0002
952 CRYING 7 0.0002
953 C-REACTIVE PROTEIN INCREASED 7 0.0002
954 NERVOUS SYSTEM DISORDER 6 0.0002
955 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
956 DEVICE LEAKAGE 8 0.0002
957 OSTEONECROSIS 6 0.0002
958 PLASMA CELL MYELOMA 7 0.0002
959 BLADDER CANCER 10 0.0002
960 RENAL CANCER 8 0.0002
961 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
962 MULTIPLE SCLEROSIS 8 0.0002
963 NO ADVERSE EVENT 30 0.0002
964 NEUTROPENIA 22 0.0002
965 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
966 COLITIS ULCERATIVE 7 0.0002
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
968 THROMBOCYTOPENIA 17 0.0002
969 FEBRILE NEUTROPENIA 10 0.0002
970 ABORTION SPONTANEOUS 6 0.0001
971 IRRITABILITY 9 0.0001
972 DRUG DEPENDENCE 24 0.0001
973 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
974 WITHDRAWAL SYNDROME 6 0.0001
975 PLATELET COUNT DECREASED 15 0.0001
976 PRODUCT STORAGE ERROR 12 0.0001
977 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
978 DISEASE PROGRESSION 16 0.0001
979 EMOTIONAL DISTRESS 16 0.0001
980 ACNE 10 0.0001
981 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
982 DRUG DOSE OMISSION BY DEVICE 10 0.0001
983 ADVERSE EVENT 11 0.0001
984 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
985 SKIN BURNING SENSATION 8 0.0001
986 DRUG ABUSE 9 0.0001
987 INJECTION SITE HAEMORRHAGE 8 0.0001
988 TREATMENT FAILURE 8 0.0001
989 DRUG DOSE OMISSION 12 0.0001
990 TOXICITY TO VARIOUS AGENTS 10 0.0001